How has been the historical performance of MPS Pharmaa?

Answer:The historical performance of MPS Pharmaa shows a consistent decline in key financial metrics over the years, particularly from 2020 to 2025. Breakdown: MPS Pharmaa's share capital has remained stable at Rs 19.11 crore from 2020 to 2025, while total reserves have worsened, moving from -10.75 crore in 2020 to -18.03 crore in 2025. Shareholder's funds have also decreased significantly, dropping from Rs 8.36 crore in 2020 to just Rs 1.08 crore in 2025. The company has maintained no long-term borrowings throughout this period, indicating a lack of debt financing. However, total liabilities have decreased from Rs 16.41 crore in 2020 to Rs 9.33 crore in 2025, primarily due to a reduction in current liabilities. The total assets have similarly declined from Rs 16.41 crore in 2020 to Rs 9.33 crore in 2025, with a notable drop in net current assets, which have remained negative, indicating ongoing liquidity issues. The book value per share has also fallen from Rs 4.38 in 2020 to Rs 0.57 in 2025, reflecting the company's deteriorating financial health. Profit before tax has been negative in several years, with a loss of Rs 1 crore in 2023 and Rs 4 crore in 2021, while cash flow from operating activities has consistently been zero or negative, highlighting ongoing operational challenges.